Refractory T-Cell Non-Hodgkin Lymphoma

specific

A T-cell non-Hodgkin lymphoma that is resistant to treatment.

21

Centers

22

Active Trials

Cancer Funding

Top Centers for Refractory T-Cell Non-Hodgkin Lymphoma(21)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
High-Volume Research Center
73.8
2
NCI Comprehensive
Active Research Program
51.3
3
NCI Comprehensive
Active Research Program
51.3
4
NCI Comprehensive
Active Research Program
51.3
5
NCI Comprehensive
Active Research Program
51.3
6
NCI Comprehensive
Active Research Program
51.3
7
NCI Comprehensive
Active Research Program
51.3
8
NCI Comprehensive
Active Research Program
51.3
951.3
10
NCI Comprehensive
Active Research Program
51.3
11
NCI Comprehensive
Active Research Program
51.3
12
NCI Comprehensive
Active Research Program
51.3
13
NCI Comprehensive
Active Research Program
51.3
14
NCI Comprehensive
Active Research Program
51.3
15
NCI Clinical
Active Research Program
51.3
16
NCI Comprehensive
Active Research Program
51.3
17
NCI Clinical
Active Research Program
51.3
18
NCI Comprehensive
Active Research Program
51.3
19
Active Research Program
51.3
20
Active Research Program
51.3
21
Active Research Program
51.3

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →